| HOME >> BIOLOGY >> TECHNOLOGY |
BUDAPEST, Hungary, September 24 /PRNewswire/ -- ThalesNano Inc., a leading developer and manufacturer of flow chemistry, flow reactor technology, and hydrogenation technology solutions, announced today that it had continued to expand globally by opening a subsidiary in the United Kingdom and by signing distributor agreements in Scandinavia, Italy, and India.
Building its own subsidiary reflects ThalesNano's commitment to bridging closer ties with its customers and expanding operations globally; it is intended to enhance activities in particular towards the chemical and pharmaceutical sectors, and to reinforce visibility. The UK representatives will bring both added value in operational terms and flexibility for customers.
Alex Drijver, CFO commented: "Chemists will have a local point of contact for advice on the most up-to-date chemistry technologies and solutions. ThalesNano Inc. was already operating successfully through a distributor company in the UK and can now strengthen and consolidate its position with help of its local team of professionals. The UK is a strategic market for the company's growth, as the country's R&D spending is the largest within Europe and has the most developed and innovative pharmaceutical and chemical industry. In this way, ThalesNano Inc. can effectively support UK customers at all times with the necessary technology knowledge."
The new UK ThalesNano team replaces former distributor Asynt Inc., with whom the company's contract expired in September. The Danish distributor company, Biolab A/S is taking over customers from Asynt Inc. in the Scandinavian region. While in Italy, Stepbio S.R.L. is the new distributor of ThalesNano products.
As a result of ThalesNano's global expansion, and as a response to the demand for its products and technologies from India, the company has started its operation through cooperation with Inkarp Instruments Pvt. Ltd.
Dr. Ferenc Darvas, president and chairman commented:
'/>"/>
| SOURCE Thalesnano Nanotechnology Inc Copyright©2007 PR Newswire. All rights reserved |